
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 6195, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1657 |
| Total Applications | 627 |
| Issued Applications | 269 |
| Pending Applications | 52 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1171857
[patent_doc_number] => 06750019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-15
[patent_title] => 'Antisense modulation of insulin-like growth factor binding protein 5 expression'
[patent_app_type] => B2
[patent_app_number] => 09/975123
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27925
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750019.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975123
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975123 | Antisense modulation of insulin-like growth factor binding protein 5 expression | Oct 8, 2001 | Issued |
Array
(
[id] => 6016927
[patent_doc_number] => 20020103154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs'
[patent_app_type] => new
[patent_app_number] => 09/965602
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 28962
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103154.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965602 | Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs | Sep 26, 2001 | Abandoned |
Array
(
[id] => 6340673
[patent_doc_number] => 20020034505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor'
[patent_app_type] => new
[patent_app_number] => 09/962489
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8350
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034505.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962489
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962489 | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor | Sep 24, 2001 | Issued |
Array
(
[id] => 6014986
[patent_doc_number] => 20020102255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies'
[patent_app_type] => new
[patent_app_number] => 09/682562
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4050
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102255.pdf
[firstpage_image] =>[orig_patent_app_number] => 09682562
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/682562 | CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies | Sep 19, 2001 | Issued |
Array
(
[id] => 6545157
[patent_doc_number] => 20020137711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Control of NK cell function and survival by modulation of SHIP activity'
[patent_app_type] => new
[patent_app_number] => 09/955174
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13466
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137711.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955174
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955174 | Control of NK cell function and survival by modulation of SHIP activity | Sep 18, 2001 | Abandoned |
Array
(
[id] => 6792511
[patent_doc_number] => 20030087855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Antisense modulation of protein kinase R expression'
[patent_app_type] => new
[patent_app_number] => 09/953611
[patent_app_country] => US
[patent_app_date] => 2001-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26179
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087855.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953611 | Antisense modulation of protein kinase R expression | Sep 12, 2001 | Abandoned |
Array
(
[id] => 6740108
[patent_doc_number] => 20030157477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Methods and reagents for identifying synthetic genetic elements'
[patent_app_type] => new
[patent_app_number] => 09/950983
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16996
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157477.pdf
[firstpage_image] =>[orig_patent_app_number] => 09950983
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/950983 | Methods and reagents for identifying synthetic genetic elements | Sep 11, 2001 | Abandoned |
Array
(
[id] => 6760835
[patent_doc_number] => 20030124196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Pulsatile release compositions and methods for enhanced intestinal drug absorption'
[patent_app_type] => new
[patent_app_number] => 09/944493
[patent_app_country] => US
[patent_app_date] => 2001-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20543
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124196.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944493 | Pulsatile release compositions and methods for enhanced intestinal drug absorption | Aug 21, 2001 | Abandoned |
Array
(
[id] => 424986
[patent_doc_number] => 07270968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'PTH analogs for renal osteodystrophy and related uses'
[patent_app_type] => utility
[patent_app_number] => 10/344744
[patent_app_country] => US
[patent_app_date] => 2001-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11293
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/270/07270968.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344744 | PTH analogs for renal osteodystrophy and related uses | Aug 13, 2001 | Issued |
Array
(
[id] => 5873960
[patent_doc_number] => 20020048814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Methods of gene silencing using poly-dT sequences'
[patent_app_type] => new
[patent_app_number] => 09/929745
[patent_app_country] => US
[patent_app_date] => 2001-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8749
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048814.pdf
[firstpage_image] =>[orig_patent_app_number] => 09929745
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/929745 | Methods of gene silencing using poly-dT sequences | Aug 12, 2001 | Abandoned |
Array
(
[id] => 6064129
[patent_doc_number] => 20020032166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Biocompatible cationic detergents and uses therefor'
[patent_app_type] => new
[patent_app_number] => 09/924898
[patent_app_country] => US
[patent_app_date] => 2001-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 18628
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032166.pdf
[firstpage_image] =>[orig_patent_app_number] => 09924898
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/924898 | Biocompatible cationic detergents and uses therefor | Aug 6, 2001 | Abandoned |
Array
(
[id] => 6801606
[patent_doc_number] => 20030096771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Antisense modulation of hormone-sensitive lipase expression'
[patent_app_type] => new
[patent_app_number] => 09/915814
[patent_app_country] => US
[patent_app_date] => 2001-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29126
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915814
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915814 | Antisense modulation of hormone-sensitive lipase expression | Jul 25, 2001 | Abandoned |
Array
(
[id] => 6870589
[patent_doc_number] => 20030083279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Antisense modulation of glioma-associated oncogene-3 expression'
[patent_app_type] => new
[patent_app_number] => 09/910185
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25106
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083279.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910185
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910185 | Antisense modulation of glioma-associated oncogene-3 expression | Jul 17, 2001 | Abandoned |
Array
(
[id] => 5873460
[patent_doc_number] => 20020048581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Modulation of nitric oxide synthase by PKC'
[patent_app_type] => new
[patent_app_number] => 09/907012
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15070
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048581.pdf
[firstpage_image] =>[orig_patent_app_number] => 09907012
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/907012 | Modulation of nitric oxide synthase by PKC | Jul 16, 2001 | Abandoned |
Array
(
[id] => 925602
[patent_doc_number] => 07316900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Methylated nucleotide regulation of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/332542
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4723
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/316/07316900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332542 | Methylated nucleotide regulation of gene expression | Jul 12, 2001 | Issued |
Array
(
[id] => 535173
[patent_doc_number] => 07173014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-06
[patent_title] => 'HIV-specific synthetic oligonucleotides and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 09/896692
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11145
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/173/07173014.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896692
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896692 | HIV-specific synthetic oligonucleotides and methods of their use | Jun 28, 2001 | Issued |
Array
(
[id] => 5936085
[patent_doc_number] => 20020061585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Ribozymal nucleic acid'
[patent_app_type] => new
[patent_app_number] => 09/880821
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8427
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09880821
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/880821 | Ribozymal nucleic acid | Jun 14, 2001 | Issued |
Array
(
[id] => 1248085
[patent_doc_number] => 06673611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'Nucleic acid molecules with novel chemical compositions capable of modulating gene expression'
[patent_app_type] => B2
[patent_app_number] => 09/866316
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21716
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866316
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866316 | Nucleic acid molecules with novel chemical compositions capable of modulating gene expression | May 24, 2001 | Issued |
Array
(
[id] => 1043606
[patent_doc_number] => 06867039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-15
[patent_title] => 'Antisense modulation of dual specific phosphatase 5 expression'
[patent_app_type] => utility
[patent_app_number] => 09/865993
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25053
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865993
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865993 | Antisense modulation of dual specific phosphatase 5 expression | May 24, 2001 | Issued |
Array
(
[id] => 6750966
[patent_doc_number] => 20030045487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Antisense modulation of phospholipase A2, group llA (synovial) expression'
[patent_app_type] => new
[patent_app_number] => 09/865866
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26804
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045487.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865866
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865866 | Antisense modulation of phospholipase A2, group llA (synovial) expression | May 24, 2001 | Abandoned |